AN ACT TO ALLOW IMMUNIZING PHARMACISTS TO ADMINISTER THE INFLUENZA VACCINE TO PEOPLE TEN YEARS OF AGE AND OLDER AND TO ADMINISTER VACCINES RECOMMENDED BY THE CENTER FOR DISEASE CONTROL AND PREVENTION TO PEOPLE AT LEAST EIGHTEEN YEARS OF AGE PURSUANT TO A WRITTEN PROTOCOL TO INCREASE ACCESS TO VACCINES IN THE BEST INTEREST OF THE PUBLIC HEALTH OF THE CITIZENS OF NORTH CAROLINA. Enacted June 3, 2019. Section 1 is effective October 1, 2019. The remainder is effective June 3, 2019.
Bill Summaries: H388 IMMUNIZING PHARMACISTS.
Summary date: Jun 3 2019 - View Summary
Summary date: Apr 8 2019 - View Summary
House committee substitute to the 1st edition makes the following changes. Expands upon the stakeholders required to collaborate to recommend a minimum standard screening questionnaire and safety procedures for written protocols for Human papillomavirus vaccine and Hepatitis A vaccine immunizations to also include the North Carolina Association of Pharmacists.
Summary date: Mar 19 2019 - View Summary
Amends GS 90-85.15B concerning the administration of vaccinations or immunizations by an immunizing pharmacist. Adds Serogroup B meningococcal vaccines, Human papillomavirus vaccine, and Hepatitis A vaccine to the vaccines and immunizations an immunizing pharmacist can administer to persons 18 years or older so long as the existing specified requirements and protocols for administration are met. Reduces the age of persons to whom immunizing pharmacists can administer the influenza vaccine pursuant to specified NCAC rules from persons at least 14 years of age to persons at least 10 years of age. Additionally, authorizes immunizing pharmacists to administer an influenza vaccine to persons at least six years of age pursuant to a specific prescription order initiated by a prescriber following a physical exam of the patient by the prescriber. Effective October 1, 2019.
Directs representatives of specified stakeholders to collaborate to recommend a minimum standard screening questionnaire and safety procedures for written protocols for Human papillomavirus vaccine and Hepatitis A vaccine immunizations, as authorized by GS 90-85.15B(6)-(7), as enacted. Requires the questionnaire and recommended standards to be submitted to the specified boards and NCGA Committee on or before August 1, 2019. In the event the deadline is not met, directs the Immunization Branch of the Division of Public Health to develop the questionnaire and recommended standards, to be submitted to the specified boards and NCGA Committee on or before September 15, 2019.